Butterfly Network, Inc.

BFLY ·Healthcare, Medical Devices, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
Operating Activities
Net Income $-77.1M $-72.5M $-133.7M $-168.7M $-32.4M $-162.7M $-99.7M
Depreciation & Amortization $6.7M $8.9M $8.7M $5.9M $2.1M $1.3M $758.0K
Depreciation — — — — — — —
Amortization — — — $3.3M $500.0K — —
Stock-Based Compensation $23.4M $21.0M $27.5M $42.5M $47.8M $11.0M $6.0M
Net Cash from Operating Activities $-12.7M $-41.7M $-98.8M $-169.1M $-189.2M $-81.7M $-120.4M
Investing Activities
Capital Expenditures $3.3M $2.7M $5.8M $18.3M $7.9M $2.4M $4.5M
Business Acquisitions — — — — — — —
Net Cash from Investing Activities $-3.3M $-2.7M $70.4M $-93.8M $-9.9M $-2.4M $-4.5M
Financing Activities
Dividends Paid — — — — — — —
Stock Repurchases — — — — — — —
Net Cash from Financing Activities $77.8M $-1.5M $228.0K $2.9M $565.7M $54.3M $324.0K
Net Change in Cash $61.7M $-45.9M $-28.2M $-260.0M $366.6M $-29.8M $-124.6M
Free Cash Flow $-16.0M $-44.4M $-104.6M $-187.4M $-197.1M $-84.1M $-124.9M